Kolexia
Landre Thierry Pharmacien
Landre Thierry
Pharmacien
Hôpital Avicenne
Bobigny, France
68 Activités
53 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Tumeurs colorectales Tumeurs du rectum Myélome multiple Plasmocytome Sarcopénie Endocardite

Collaborateurs

Voir plus
Des Guetz Gaëtan
Des Guetz Gaëtan
Centre Hospitalier de Saint-Denis, Saint-Denis, France
Taleb Cherifa
Taleb Cherifa
Hôpital Jean Verdier, Bondy, France
Chouahnia Abdel Kader
Chouahnia Abdel Kader
Hôpital Avicenne, Bobigny, France
Chouaid Christos
Chouaid Christos
Centre Hospitalier Intercommunal Créteil, Créteil, France

Industries

Voir plus
AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC).
Journal of chemotherapy (Florence, Italy)   01 février 2024
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis.
ESMO open   16 janvier 2024
1428P Clinical benefit of combination chemo-immunotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic NSCLC
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis.
Cancers   30 novembre 2021
971P Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
1600P Suboptimal response to COVID-19 mRNA vaccines in older patients with cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.
Cancer immunology, immunotherapy : CII   10 août 2021
Anti PD-(L)1 in KRAS mutant advanced nsclcs: A meta-analysis of randomized controlled trials.
2021 ASCO Annual Meeting I   28 mai 2021
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis.
Cancers   28 mars 2021
Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis.
Drugs & aging   20 janvier 2021